Nasa trials TINY supersonic ‘Son of Concorde' for 925mph flight in tunnel – but prototype airplane measures just inches
AIR WE GO! Nasa trials TINY supersonic 'Son of Concorde' for 925mph flight in tunnel – but prototype airplane measures just inches
Click to share on X/Twitter (Opens in new window)
Click to share on Facebook (Opens in new window)
NASA researchers have been using a tiny aircraft dubbed "Son of Concorde" in trials to assess the impact of supersonic flights on residents.
The tests took place in a wind tunnel in Japan measuring just 3ft by 3ft.
Sign up for Scottish Sun
newsletter
Sign up
1
The tiny 'Son of Concorde' undergoes tests in a wind tunnel in Japan
At present there is a ban on supersonic flights over land as researchers scramble to find new ways to limit the impact at ground level.
The latest tests come after President Trump ordered the Federal Aviation Administration to scrap a longstanding ban on supersonic air travel across the US.
He wants to replace it with a to-be-determined set of regulations that will allow faster-than-sound travel so long as the sonic booms it creates do not breach certain noise limitations.
In an executive order signed in June, Trump directed the FAA administrator to begin the process of repealing a section of the Code of Federal Regulations that prohibits anyone in the United States from flying a civilian aircraft 'at a true flight Mach number greater than 1'.
Read more in Tech
UP AND AWAY 'Son of Concorde' bosses reveal over 600 routes could see flight times HALVED
That regulation was imposed in April 1973, at a time when the British and French governments were jointly developing Concorde, a supersonic airliner that had a cruising speed in excess of Mach 2, or twice the speed of sound.
Engineers from Nasa and the Japanese Aerospace Exploration Agency (JAXA) completed the fresh round of supersonic testing using a miniature version of Nasa's X-59 quiet-supersonic experimental aircraft in the trials.
Vid shows supersonic test launch in bid for 1hr cross-Atlantic flights in 5yrs
The campaign was conducted at JAXA's facility in Chofu, Tokyo.
It assessed how the aircraft's pressure signature, audible on the ground as a sonic 'thump,' will reach people beneath its flight path.
The X-59 demonstrator measures 99.7ft in length with a 29.7-ft wingspan, but the Chofu tunnel could only accommodate the miniature model, which is just 1.62% of the real jet.
Engineers nevertheless subjected the replica to airflow conditions representing the aircraft's planned cruise of Mach 1.4 – about 925 miles per hour.
By comparing the wind-tunnel data with detailed Computational Fluid Dynamics predictions, Nasa can validate how air will wrap around the jet's slender fuselage and long, highly swept wing.
Critically, it will also show how its shock waves are expected to behave.
Unlike conventional supersonic airplanes, whose shock waves combine into a single, ground-shaking blast, the X-59's carefully sculpted nose and chine are intended to separate those waves.
The goal is a brief, low-volume 'sonic thump' rather than an ear-splitting boom, opening the door to overland supersonic passenger flight, reports Interest Engineering.
The Chofu tests mark the third time the model has entered a wind tunnel, following earlier runs at JAXA and NASA's Glenn Research Center in Ohio.
Researchers delivered 'critical experimental data to compare to…predictions", Nasa noted.
The X-59 is the centerpiece of NASA's Quesst mission, an effort to prove that quiet supersonic flight is technically and socially viable.
Once airborne, the jet will make a series of community overflights across the United States so researchers can gauge how residents react to its muted acoustic footprint.
Their feedback, combined with the aerodynamic and acoustic data now being amassed in wind tunnels and ground tests, will inform regulators as they consider lifting the decades-old ban on supersonic flight over land.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Glasgow Times
3 hours ago
- Glasgow Times
Fundraiser launched after Scottish woman dies in Spain
Angela Mctier, who is understood to be from Blantyre, became unwell and passed away while coming home from her holiday in Alicante, Spain, yesterday (July 22). Now, a fundraiser has been launched on GoFundMe to help Angela's family bring her home. The description reads: "We are just looking to take a bit of stress off Angela's family to bring her home and let her get laid to rest. "Any donations at all would be greatly appreciated." So far, more than £750 has been raised. A Foreign, Commonwealth and Development Office (FCDO) spokesperson confirmed: "We are supporting the family of a British woman who died in Spain." You can view the GoFundMe HERE.
Daily Mail
5 hours ago
- Daily Mail
Contraception used by thousands increases risk of brain tumour, study finds
Women on a widely–used contraceptive jab are three–and–a–half times more likely to suffer a potentially–fatal brain tumour, a study shows. It's the third major investigation in just over a year to show the jab raises the risk of a meningioma, the most common type of tumour in the brain, in those on it for 12 months or more. Around 10,000 prescriptions a month are issued for medroxyprogesterone acetate— sold under the brand name Depo Provera—in England alone. Hundreds of women in the UK are now reported to be considering legal action against the manufacturer Pfizer, for not warning them of the risks. A class action is already underway against Pfizer and other generic manufacturers of the jab in the US, where more than 500 women allege the companies were aware of the link but failed to adequately warn users of the risks or promote safer alternatives. The drug is a hormone injection give every three months and works by preventing eggs from being released by a woman's ovaries. It was first licensed for use on the NHS as a contraceptive over 40 years ago. But a 2024 study in the British Medical Journal of more than 18,000 women, by a team of scientists from the French National Agency for Medicines and Health Products Safety, concluded those who stayed on it for at least a year were up to five times more at risk of a meningioma. The jab is administered every three months in a doctor's surgery or sexual health clinic A second probe in September last year, by researchers at the University of Alabama in the US, produced similar results. Although non–cancerous, the condition can cause blurred vision, headaches, hearing loss, poor sense of smell and problems with swallowing. Tumours are normally slow–growing but can kill by compressing the brain and nerves if they grow too big. Between 2,000 and 3,000 people a year in the UK are diagnosed with a meningioma and it's more common in women. In the latest study, scientists at the University of British Columbia in Vancouver, Canada, compared meningioma rates in 72,181 women on the jab with more than 247,000 women on oral contraception. The results, in the journal Expert Opinion on Drug Safety, showed the risks were more than trebled in long–term users of the jab. Researcher Dr Mahyar Etminan said the dangers did not appear to increase the more years women spent on the drug. But he added: 'I do believe the evidence is now robust, with three large studies showing pretty much the same thing. 'Women concerned about this risk may want to consider opting for alternative contraceptives.' It's not clear why the jab triggers tumour growth. One theory is the synthetic hormone it uses – progestogen – binds to meningioma cells and helps them grow. Some research suggests certain versions of the Pill made with progestogen can also heighten the risk of meningioma but only in a small proportion of women who take it for more than five years. The UK drug safety watchdog—the Medicines and Healthcare Products Regulatory Agency—last October called on Pfizer to include a warning about the heightened risk in patient information leaflets. Pfizer also wrote to NHS doctors urging them to immediately stop women from using Depo Provera if they were diagnosed with a meningioma. Virginia Buchanan, partner at Levin Papantonio—the law firm handling the case in the US—said: 'This new study reinforces the need for legal action against Pfizer, with the hope of bringing justice for the women who have never been warned about the increased risk of developing a brain tumour from using Depo–Provera and who have gone on to develop meningiomas.'
Daily Mirror
5 hours ago
- Daily Mirror
MoD admits Britain's troops could have brain damage caused by their own weapons
Senior British officers and scientists admit British troops may suffer 'brain damage' caused by low impact blasts from their own weapons while fighting on the frontline Thousands of UK troops could have brain damage caused by their own weapons, defence chiefs have confirmed. Blast waves repeatedly caused by explosions from weapons could have led to life-long health issues, it has been revealed. The Ministry of Defence's lead officer on Traumatic Brain Injury (TBI) Lt Col James Mitchell admitted exposure to weapons blasts could cause the injuries. He told ITV News that in Iraq and Afghanistan, TBI and concussion was caused by larger explosions and blasts. But in fact low level blasts may cause health problems. Lt Col Mitchell told ITV News: "Over especially the last five to ten years, we're starting to appreciate the role of what we call low level blasts.' He said low level blasts were predominantly being caused by "the exposure of our service personnel to blast over-pressure from their own weapons systems." Lt Col Mitchell said 'thousands' of personnel may have been exposed to harmful blasts. Most at risk are troops exposed to heavy weapons like mortars, shoulder-launched anti-tank weapons, 50-calibre rifles and machine guns, or explosive charges. Explosions create a wave of 'overpressure', a spike in the surrounding air pressure above normal atmospheric levels caused by a blast wave. The force is so strong it enters the skull and can cause microscopic damage to blood vessels and neurons. Repeated exposure means the brain may not heal itself, causing serious long-term neurological damage. Symptoms of blast-related TBI overlap with those of Post Traumatic Stress Disorder (PTSD), making it difficult to diagnose. They are severe headaches, sight problems, sensitivity to noise and light, memory loss and a sense of personality change. Scientists are probing the causes of TBI, with financial support from the MoD. The University of Birmingham is playing a key role in the mild TBI study in partnership with the MoD, which aims to estimate what kind of brain damage veterans have. Professor Lisa Hill, a neuroscientist at Birmingham University said: 'If somebody gets injured, it changes the structure and function of the brain, but it also releases chemicals that you wouldn't normally see,' she said. 'So if we can measure things in blood or in their saliva, that can tell us how potentially bad their injury has been and what symptoms they might go on to get.' Hugh Keir, a Para Regiment sniper who fought in Iraq and Afghanistan, now runs the H-Hour podcast which is popular with veterans in the UK and abroad. He volunteered to undergo a trial scan to see if his years of exposure to blast have left a mark. The results showed normal brain activity overall, but there were some signs that may indicate damage. Professor Mullinger also plans to study soldiers in real time, to see which activities are highest risk. 'We can scan these soldiers before they go and do a training exercise and then immediately after, then we get a baseline which is specific to them,' she said. 'If the 'wire paths' have been damaged by blasts or whatever else it might be, then the function is going to change.' The information collected from these trials could shape policy, such as modifying the most damaging weapons or reducing blast exposure in training exercises. British troops throughout the Afghan and Iraq wars were repeatedly exposed to firefights, explosions from bombs and mortars, especially being fired by their own side. Thousands have suffered hearing loss from the blasts but the new research suggests lower-grade blasts may have caused long-term issues. Sources said the research into the issue is ongoing and may result in protective gear used by soldiers may be investigated and further improved in a bid to protect against the blast waves. An estimated 300,000 armed forces personnel suffering with hearing loss caused by the relentless noise of military life. Hearing loss and tinnitus is much more common in the military population than the general public. In fact, by the age of 75, service personnel are 3.5 times more likely to experience hearing difficulties than the general public. The UK Armed Forces has a number of compensation schemes for serving and former serving personnel who have been injured as a result of their service in the armed forces. If the injury was caused prior to April 6 2005 and the person is no longer serving this would be the War Pension Scheme (WPS). The Armed Forces Compensation Scheme (AFCS) was established for soldiers injured after 2005 who are still in active service. However the criteria to claim for both schemes is arduous and in-depth.
